Early research (Phase 1)Study completedNCT01670734
What this trial is testing
Pharmacokinetic and Tolerability of Alirocumab SAR236553 (REGN727) in Patients With Hepatic Impairment and in Healthy Subjects
Who this might be right for
Hypercholesterolemia
Sanofi 25